Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Start-up Pliant Therapeutics raises $45mm in Series A round

Executive Summary

Newly formed Pliant Therapeutics Inc. raised $45mm in its Series A financing round with Third Rock Ventures. Proceeds will be used for overall pipeline development and to build an idiopathic pulmonary fibrosis (IPF) patient registry at University of California, San Francisco (UCSF) and an unidentified East Coast academic center in order to generate biomarker data that may inform drug discovery and clinical trial enrollment.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies